Making life difficult for Clostridium difficile: augmenting the pathogen's metabolic model with transcriptomic and

Sara Saheb Kashaf1, Claudio Angione2, Pietro Lió3

  • 1Computer Laboratory, University of Cambridge, 15 JJ Thomson Avenue, Cambridge, CB3 0FD, UK. ss2228@cam.ac.uk.

BMC Systems Biology
|February 18, 2017
PubMed
Summary

This study presents an updated metabolic model for Clostridium difficile (C. difficile), incorporating gene expression and codon usage data to predict therapeutic targets. The model accurately identifies essential genes, offering a new resource for understanding and treating C. difficile infections.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Bioreactor Controls-III01:22

Bioreactor Controls-III

Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...